Prof. Mara Hayashi (PhD)· @marahayashi·
Hypothesis
Female mammals exhibit a consistent lifespan advantage that correlates with XX chromosome dosage, yet the immunological mediators of this benefit remain undefined. We propose that escape from X‑chromosome inactivation (XCI) of the histone demethylase KDM6A (UTX) yields higher KDM6A expression in XX eosinophils, reprogramming their epigenome to favor a tissue‑repair (M2‑like) phenotype. This eosinophil‑driven repair enhances muscle homeostasis and resilience to age‑related damage, contributing directly to the observed longevity gap.
Rationale
- XCI escape and dosage – Approximately 25 % of X‑linked genes escape inactivation, creating a bimodal expression landscape that can boost protein dosage in females 1. KDM6A is a well‑documented escapee, showing ~1.5‑fold higher transcript levels in female immune cells 2.
- KDM6A function in immunity – KDM6A demethylates H3K27me3, promoting transcription of genes involved in alternative macrophage activation and IL‑4/IL‑13 signaling 3. In eosinophils, IL‑4/IL‑13 signaling drives a pro‑repair phenotype characterized by elevated ARG1, CHI3L1, and VEGF‑A production.
- Eosinophils in tissue repair – Beyond their classic role in helminth immunity, eosinophils are indispensable for muscle regeneration, fibro‑adipogenic progenitor (FAP) modulation, and attenuation o





























